Pnc Financial Services Group, Inc. Maxcyte, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $156 Billion
- Q3 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Maxcyte, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 24,188 shares of MXCT stock, worth $85,141. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,188
Previous 19,287
25.41%
Holding current value
$85,141
Previous $75,000
25.33%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding MXCT
# of Institutions
124Shares Held
65.6MCall Options Held
1KPut Options Held
2K-
Cadian Capital Management, LP New York, NY8.19MShares$28.8 Million1.63% of portfolio
-
Black Rock Inc. New York, NY8.14MShares$28.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.78MShares$20.3 Million0.0% of portfolio
-
Vitruvian Partners LLP5.04MShares$17.8 Million7.62% of portfolio
-
Morgan Stanley New York, NY4.82MShares$17 Million0.0% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $358M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...